Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate

NCT01676701 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT01676701
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01676701 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Lead sponsor
Eli Lilly and Company
Phase
Phase 3
Overall status
Terminated
Start date
September 30, 2012
Completion date
August 31, 2013
Enrollment
8 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis